12:00 AM
Feb 22, 2000
 |  BC Week In Review  |  Company News  |  Deals

Creative BioMolecules, Ontogeny, Reprogenesis deal

The three regenerative medicine companies will merge to form Curis Inc. Shareholders of CBMI, Ontogeny and Reprogenesis will own 43, 38 and 19 percent, respectively, of the merged company. Based on CBMI’s...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >